Form CERT - Certification by an exchange approving securities for listing:
SEC Accession No. 0001354457-21-001208
Filing Date
2021-10-22
Accepted
2021-10-22 16:21:25
Documents
1
Effectiveness Date
2021-10-22

Document Format Files

Seq Description Document Type Size
1 8A_Cert_BTX.pdf CERT 179929
  Complete submission text file 0001354457-21-001208.txt   249299
Mailing Address 140 58TH STREET, BUILDING A SUITE 2100 BROOKLYN NY 11220
Business Address 140 58TH STREET, BUILDING A SUITE 2100 BROOKLYN NY 11220 (212) 582-1199
Brooklyn ImmunoTherapeutics, Inc. (Filer) CIK: 0000748592 (see all company filings)

EIN.: 311103425 | State of Incorp.: DE | Fiscal Year End: 1231
Type: CERT | Act: 34 | File No.: 001-11460 | Film No.: 211340759
SIC: 2834 Pharmaceutical Preparations